NanoPilotProject ID: 646142
Financé au titre de:
H2020-EU.18.104.22.168. - Developing next generation nanomaterials, nanodevices and nanosystems
A Pilot Plant for the Production of Polymer based Nanopharmaceuticals in Compliance with GMP
Détails concernant le projet
Coût total:EUR 6 283 988,75
Contribution de l'UE:EUR 6 283 988,75
Appel à propositions:H2020-NMP-PILOTS-2014See other projects for this call
Régime de financement:RIA - Research and Innovation action
The aim of NanoPilot will be to set-up a flexible and adaptable pilot plant operating under GMP for the production of small batches of polymer-based nanopharmaceuticals, which exhibit significant potential in the field of drug-delivery particularly for the design of second-generation nanopharmaceuticals.
Three different processes will be established for the production of three different nanopharmaceuticals selected on the basis of their TRL and positive commercial evaluation: a) topical treatment of ocular pain associated with dry eye syndrome containing short interfering RNA and lactic acid, b) A resuspendable HIV nanovaccine for intranasal vaccination containing 12 peptides in its formulation. c) Hyaluronan based hollow spheres intended for intravesical instillation, for the treatment of interstitial cystitis/painful bladder syndrome.
State of the art production processes including micro reactors and highly advanced characterization techniques will ensure the quality of the nanodrugs. Existing laboratories suitable for large-scale production of biologics in compliance with GMP, and owned by the coordinator, will be adapted and certified within this project to enable the operability of the pilot plant.
NanoPilot consists of nine complementary partners composed by 1 Industry and 2 academia developers of the nanosystems to scale-up. A research Institute expert in nanoparticle characterizacion and already operating in compliance with Good laboratory practices. An SME and an Industry that will develop ad-hoc continuous flow reactors for the optimization of two of the three processes. A consultancy (SME) expert in Quality system implementation and laboratory information management systems. A second consultancy (SME) in charge of the business plan, that will also help the coordinator in dissemination and exploitation activities. Finally, a research centre with a recorded track in nanomedicine, already operating under ISO 9001, and will be in charge of the pilot plant.
Contribution de l'UE: EUR 2 045 560
Parque Tecnologico de Miramon, Paseo Miramon 196
20009 DONOSTIA - SAN SEBASTIAN
Contribution de l'UE: EUR 531 500
Contribution de l'UE: EUR 273 500
PAZO DE SAN XEROME, PRAZA DO OBRADOIRO S/N
15782 SANTIAGO DE COMPOSTELA
Contribution de l'UE: EUR 643 118,75
PLAZA DESCUBRIDOR DIEGO DE ORDAS 3
Contribution de l'UE: EUR 84 973,21
KONRAD ADENAUER ALLEE 11
Contribution de l'UE: EUR 586 450
6167 RD GELEEN
Contribution de l'UE: EUR 981 662,50
CALLE AGUSTIN QUEROL 8
Contribution de l'UE: EUR 198 441,25
Contribution de l'UE: EUR 670 750
AVENUE DU DOCTEUR ALBERT SCHWEITZER - CENTRE CONDORCET 162
Contribution de l'UE: EUR 268 033,04